Pandemic influenza A virus vaccines (CSL/NIAID)

N/A

Report date: 2026/03/14 20:00:17

Base Information

Drug NamePandemic influenza A virus vaccines (CSL/NIAID)
Drug Alias Name甲型流感病毒疫苗 - CSL/NIAIDInfluenza A virus H5N1/H9N2 subtypes vaccine流行性流感A病毒疫苗 - CSL/NIAIDFocetria (Mock-up)Foclivia +[6] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiabetes MellitusHeart DiseasesLung Diseases +[5] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/10/18
Country/TerritoryPolandTurkeyAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Novartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus Srl
Inactive CompaniesSeqirusNovartis VaccinesChiltern - Pesquisa Clinica Ltda
Active IndicationsInfluenza, Human
Inactive IndicationsDiabetes MellitusHeart DiseasesLung Diseases +[4] 

Other Information

ATC CodeJ07BB
Related LinksN/A